Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
RPRX
#500
Royalty Pharma plc Class A Ordinary Shares
46.210
0
+2.45%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
+2.45%
Monthly Change
+13.99%
6 month change
+24.02%
Year Change
+24.02%
Previous Close
45.105
0
Open
46.210
0
Bid
Ask
Low
46.210
0
High
46.210
0
Volume
225
Markets
US Stock Market
Healthcare
RPRX
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
388.13 M
432.96 M
443.17 M
446.69 M
433.32 M
428.42 M
—
Valuation ratios
Enterprise value
303.91 T
242 T
239.29 T
168.93 T
147.08 T
222.94 T
811.84 T
Price to earnings ratio
31.16
39.04
394
11.17
13.36
21.71
70.31
Price to sales ratio
8.85
7.22
7.71
7.24
6.7
9.17
34.98
Price to cash flow ratio
14.93
11.99
8.05
5.7
5.47
8.76
32.76
Price to book ratio
6.31
4.19
3.07
2.61
2.18
3.37
5.6
Enterprise value to EBITDA ratio
168.52 K
113.31 K
577.4 K
109.36 K
120.6 K
150.62 K
509.31 K
Profitability ratios
Return on assets %
0.06
0.04
0
0.07
0.05
0.04
0.04
Return on equity %
0.1
0.06
0
0.11
0.08
0.08
0.08
Return on invested capital %
45.75
39.11
7.99
38.15
30.83
34.06
34.9
Gross margin %
92.64
99.44
50.92
75.24
63.21
86.46
343.51
Operating margin %
75.17
62.49
13.73
63.37
57.1
65.58
262.81
EBITDA margin %
84.97
93.29
18.52
65.6
53.88
62.24
248.14
Net margin %
45.94
27.07
1.91
48.2
37.95
32.42
128.9
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
8.76
16.81
2.19
7.9
1.44
2.4
8.7
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.13
0.14
0.13
0.14
0.13
0.13
0.13
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0.36
0.41
0.36
0.37
0.36
0.44
1.64
Long term debt to total equity ratio
1.21
1.23
1.09
0.94
0.95
1.32
4.75
Per share metrics
Operating cash flow per share
3.35
3.32
4.9
4.96
4.66
4.41
4.4
EBIT per share
2.91
3.45
0.88
2.53
2.02
2.58
2.59
EBITDA per share
2.97
3.52
0.95
2.56
2.05
2.62
2.63
Total debt per share
—
—
—
—
—
—
—
Cash per share
3.4
3.61
3.96
0.82
1.66
1.13
5.89
Net current asset value per share
4.44
4.74
5.83
2.11
3.03
2.71
11.9
Tangible book value per share
12.76
13.91
12.85
10.83
11.69
9.84
40.86
Working capital per share
3.94
4.46
3.17
1.85
0.92
1.58
5.64
Book value per share
7.94
9.51
12.85
10.83
11.69
11.47
45.8
News
TD Cowen raises Royalty Pharma stock price target to $50 on growth
Royalty Pharma stock hits 52-week high at 46.14 USD
Royalty Pharma Stock: 2025 Financial Performance And Strategic Outlook (NASDAQ:RPRX)
The Week That Was, The Week Ahead: Macro and Markets, Feb. 15 - TipRanks.com
Dividend Champion, Contender, And Challenger Highlights: Week Of February 15
Royalty Pharma plc (RPRX) Q4 2025 Earnings Call Transcript
Royalty Pharma stock hits 52-week high at 44.94 USD
Royalty Pharma Q4 2025 slides: double-digit growth amid synthetic royalty expansion
Here's What Key Metrics Tell Us About Royalty Pharma (RPRX) Q4 Earnings
Royalty Pharma earnings beat by $0.22, revenue topped estimates
McDonald’s, Cisco, Shopify, and more set to report earnings Wednesday
Royalty Pharma earnings in focus after $4.7B deal spree